Enterprise Solutions Webinars

  1. Single-Use Assembly Configurator Tutorial 10/31/2025

    Master the essentials of single-use assembly design. Learn how a step-by-step configurator with 3D renderings simplifies complex fluid management challenges and accelerates your process.

  2. Developing Your Risk-Based Approach To Single-Use System Integrity 10/29/2025

    Explore how a holistic approach to single-use system integrity can strengthen contamination control, improve operational efficiency, and meet evolving regulatory expectations in manufacturing.

  3. Smarter CMC Strategies To Accelerate Next-Gen Biologics To The Clinic 10/23/2025

    Learn how process design and cross-functional collaboration mitigate risks and accelerate the path from early development to FIH manufacturing through real-world case studies of practical approaches.

  4. Your Journey To GMP With Emphasis On Linker Payload Development 10/22/2025

    Develop lower-risk conjugation strategies by incorporating the critical insights we highlight in our review of semi-synthetic versus synthetic linker–payloads and their respective advantages and limitations.

  5. Optimizing CMC Strategy For Successful Scale-Up 10/22/2025

    In this segment from the Bioprocess Online Live event “Evolving CMC Strategies To Enable Next-Gen ADCs,” panelists Michael Torres, Ph.D. (CrossBridge Bio), Morris Rosenberg, Ph.D. (CrossBridge Bio), and Borys Shor, Ph.D. (OS Therapies and Manhattan BioSolutions) share advice on developing CMC strategies in a way that strengthens manufacturability through careful assay development and collaboration with CDMOs.

  6. Developing Analytical Methods For Advanced ADCs 10/22/2025

    Advanced molecules, especially ADCs with novel constructs, require extensive characterization testing. In this segment from the Bioprocess Online Live event “Evolving CMC Strategies To Enable Next-Gen ADCs,” panelists Michael Torres, Ph.D. (CrossBridge Bio), Morris Rosenberg, Ph.D. (CrossBridge Bio), and Borys Shor, Ph.D. (OS Therapies and Manhattan BioSolutions) discuss the nuances of analytical methodology for advanced ADCs and emphasize the importance of potency assays. They also share their thoughts on how much CMC development companies should aim to do internally before working with development partners.

  7. CMC Challenges Facing Next-Generation ADCs 10/22/2025

    In this segment from the Bioprocess Online Live event “Evolving CMC Strategies To Enable Next-Gen ADCs,” panelists Michael Torres, Ph.D. (CrossBridge Bio), Morris Rosenberg, Ph.D. (CrossBridge Bio), and Borys Shor, Ph.D. (OS Therapies and Manhattan BioSolutions) weigh in on the biggest challenges to ADC development, particularly navigating geopolitical tensions in a time of increasingly global manufacturing operations.

  8. Game-Changing CLD Platforms: Strategies, Technologies, Workflows 10/21/2025

    Selecting the right cell line platform is complex. Learn how flexible strategies, integrated technologies, and expert workflows enable high productivity, rapid timelines, and a de-risked path to clinical success.

  9. medac CDMO Capacity Update October 2025: Fill/Finish 10/20/2025

    Find more than just reliable, flexible support along the entire value chain of injectables. Learn how dual-site EU-based operations provide scalable capacity and seamless global supply for your molecules.

  10. Regulatory Confidence, Manufacturing Excellence 10/20/2025

    With decades of experience, we offer a flexible and collaborative partnership model for manufacturing excellence that enables our clients to increase speed to market with full regulatory confidence.